<HashMap><database>bioimages</database><scores/><additional><omics_type>Unknown</omics_type><submitter/><species>Streptococcus pneumoniae</species><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-BIAD477</full_dataset_link><repository>bioimages</repository><figure_sub>Protocols</figure_sub><figure_sub>Study Component</figure_sub><figure_sub>organisation</figure_sub><figure_sub>Study Protocols</figure_sub><pubmed_authors>Liselot Dewachter</pubmed_authors><pubmed_authors>Jan-Willem Veening</pubmed_authors></additional><is_claimable>false</is_claimable><name>Images for "Amoxicillin-resistant Streptococcus pneumoniae can be resensitized by targeting the mevalonate pathway as indicated by sCRilecs-seq"</name><description>Antibiotic resistance in the important opportunistic human pathogen Streptococcus pneumoniae is on the rise. This is particularly problematic in the case of the β-lactam antibiotic amoxicillin, which is the first-line therapy. It is therefore crucial to uncover targets that would kill or resensitize amoxicillin-resistant pneumococci. To do so, we developed a genome-wide, single-cell based, gene silencing screen using CRISPR interference called sCRilecs-seq (subsets of CRISPR interference libraries extracted by fluorescence activated cell sorting coupled to next generation sequencing). Since amoxicillin affects growth and division, sCRilecs-seq was used to identify targets that are responsible for maintaining proper cell size. Our screen revealed that downregulation of the mevalonate pathwa</description><dates><release>2022-06-09T00:00:00Z</release><modification>2023-04-08T16:17:10.604Z</modification><creation>2022-06-10T12:38:46.794Z</creation></dates><accession>S-BIAD477</accession><cross_references/></HashMap>